Recognizing David Sparks for Contributions to Pharmaceutical Industry

Floor Speech

BREAK IN TRANSCRIPT

Mr. CARTER of Georgia. Mr. Speaker, I rise today to recognize David Sparks for his outstanding contributions and visionary leadership in the pharmaceutical industry.

As the previous CEO and current chairman of the board at the Professional Compounding Centers of America, PCCA, Mr. Sparks has been instrumental in advancing the pharmaceutical industry. Since joining PCCA in 1992, he has fought to protect pharmacists' rights to compound, playing a key role in FDA reform legislation. Before PCCA, he owned pharmacies in Tulsa for over two decades, pioneering the introduction of compounding pharmacies in hospice care.

Committed to education, Mr. Sparks is a proud contributor to the SWOSU general scholarship fund, ensuring that future pharmacists have the essential resources to succeed. He is also an adjunct professor at the University of Houston College of Pharmacy and an active member of its Mading Society of benefactors. He remains a dedicated advocate for the advancement of pharmacy, continuously supporting the profession through leadership and philanthropy.

Mr. Sparks' impact on the pharmaceutical industry is profound and lasting, and his leadership will continue to shape its future. Recognizing Jim Smith for Leadership in Pharmaceutical Compounding

BREAK IN TRANSCRIPT

Mr. CARTER of Georgia. Mr. Speaker, I rise today to recognize Jim Smith, a distinguished leader whose dedication and vision have profoundly impacted both the Professional Compounding Centers of America, PCCA, and the healthcare industry.

His educational background, including a bachelor of science in chemistry and biology from West Texas A&M University and an MBA from the University of Portland, has shaped his strategic leadership.

Since joining PCCA in 2000, Mr. Smith has played a crucial role in the organization's growth, serving as president, chief operating officer, vice president of sales and marketing, and a key member of the strategic management team. His leadership has strengthened PCCA's core capabilities, driving innovation and excellence in pharmaceutical compounding.

Prior to his tenure, Mr. Smith leveraged his expertise in home health, specialty medicine, respiratory pharmacy, long-term care pharmacy, and compounding support, demonstrating his commitment to advancing patient care.

Today, as executive adviser to the PCCA board of directors, Mr. Smith continues to shape the industry, ensuring that innovation and patient care remain at the forefront.

Mr. Smith's dedication exemplifies the highest standards of leadership and service. Congratulating Gus Bassani, a Visionary in Pharmaceutical Compounding

BREAK IN TRANSCRIPT

Mr. CARTER of Georgia. Mr. Speaker, I rise today to congratulate Gus Bassani, a longtime leader and visionary in the pharmacy compounding industry who has recently assumed the role of chief executive officer of the Professional Compounding Centers of America, PCCA.

Mr. Bassani earned his doctor of pharmacy degree from Drake University's College of Pharmacy and Health Sciences. Since then, he has been invaluable in various settings within the pharmaceutical industry.

Mr. Bassani embraces opportunities to give back, teaching extemporaneous compounding principles to pharmacy students at Drake University.

Mr. Bassani has been with PCCA since September 2002, actively participating in legislative, regulatory, and public affairs initiatives. At PCCA, he has been a visionary, contributing extensively to the organization's scientific, technical, and strategic pursuits.

In addition to his outstanding work with PCCA, Mr. Bassani has previously served on the United States Pharmacopeia Compounding Expert Committee.

Mr. Speaker, I congratulate Mr. Bassani on this exciting achievement, and I wish him the best in his new role.

BREAK IN TRANSCRIPT

Source